Joe Bolen

Joe Bolen

Amministratore Delegato presso
Orna Therapeutics, Inc.
72 anni
Health Technology
Consumer Services
Finance

Profilo

Joseph B. Bolen is currently Chief Executive Officer at Orna Therapeutics, Inc. starting in 2025 and serves as an Independent Director at Aelin Therapeutics NV.
Formerly, Dr. Bolen was Chief Scientific Officer at PureTech Health Plc from 2016 to 2023, Partner at MPM BioImpact LLC in 2026, President & Chief Scientific Officer at Moderna, Inc. and ModernaTX, Inc., Vice President & Head-Oncologic Diseases at Hoechst Marion Roussel, Inc., Advisor at Robert Wood Johnson Medical School, Scientist at National Institutes of Health, Professor & Member-Graduate Faculty at Princeton University, Member-Scientific Advisory Board at Rutgers State University of New Jersey, Chief Scientific Officer & Head-Oncology Research at Millennium Pharmaceuticals, Inc., Founding Director at DNAX Research, Inc., and Director-Cellular Signaling Department at Bristol-Myers Squibb Pharma Research Labs LLC in 2012.
Education includes undergraduate studies at the University of Nebraska and a doctorate from Kansas State University.

Posizioni attive di Joe Bolen

SocietàPosizioneInizio
Direttore/Membro del Consiglio -
Amministratore Delegato 31/03/2025

Precedenti posizioni note di Joe Bolen

SocietàPosizioneFine
Investitore di Private Equity 01/06/2026
PURETECH HEALTH PLC Direttore Tecnico/Scientifico/R&S 01/02/2023
MODERNA, INC. Presidente -
Direttore Tecnico/Scientifico/R&S -
DNAX Research, Inc.
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Joe Bolen

Formazione di Joe Bolen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

43

Relazioni di 1° grado

16

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private16

Health Technology

Consumer Services

Finance

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Government

Consumer Services

Health Technology

DNAX Research, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA